- Home
- TECX vs LAB Comparison
TECX vs LAB Comparison
Compare TECX & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- LAB
- Stock Information
- Founded
- TECX 2019
- LAB 1999
- Country
- TECX United States
- LAB United States
- Employees
- TECX N/A
- LAB N/A
- Industry
- TECX
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- TECX
- LAB Industrials
- Exchange
- TECX Nasdaq
- LAB Nasdaq
- Market Cap
- TECX 647.7M
- LAB 562.1M
- IPO Year
- TECX 2018
- LAB 2011
- Fundamental
- Price
- TECX $44.89
- LAB $1.62
- Analyst Decision
- TECX Strong Buy
- LAB Strong Buy
- Analyst Count
- TECX 5
- LAB 2
- Target Price
- TECX $72.25
- LAB $2.88
- AVG Volume (30 Days)
- TECX 140.0K
- LAB 2.8M
- Earning Date
- TECX 11-07-2024
- LAB 10-30-2024
- Dividend Yield
- TECX N/A
- LAB N/A
- EPS Growth
- TECX N/A
- LAB N/A
- EPS
- TECX N/A
- LAB N/A
- Revenue
- TECX N/A
- LAB $155,902,000.00
- Revenue This Year
- TECX N/A
- LAB $62.60
- Revenue Next Year
- TECX N/A
- LAB $9.91
- P/E Ratio
- TECX N/A
- LAB N/A
- Revenue Growth
- TECX N/A
- LAB 48.23
- 52 Week Low
- TECX $1.40
- LAB $1.21
- 52 Week High
- TECX $48.63
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- TECX 61.61
- LAB 39.48
- Support Level
- TECX $37.50
- LAB $1.46
- Resistance Level
- TECX $48.63
- LAB $1.69
- Average True Range (ATR)
- TECX 3.47
- LAB 0.15
- MACD
- TECX -0.63
- LAB -0.05
- Stochastic Oscillator
- TECX 66.40
- LAB 18.60
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.